Document is current
Any future updates will be listed below
-
Authors
Zárate-Pinzón, Laura
Mejía-Salgado, Germán https://orcid.org/0000-0002-1241-0715
Cifuentes-González, Carlos
Correa-Jiménez, Oscar https://orcid.org/0000-0001-6007-2821
Amaris, Stefania
Alfaro-Murillo, Alberto https://orcid.org/0000-0002-0770-3943
Téllez-Zambrano, Juanita
Verbel, Angie
Monje-Tobar, Paula
de-la-Torre, Alejandra https://orcid.org/0000-0003-0684-1989
-
Funding
Funding for this research was provided by:
Universidad del Rosario
- License Information
-
More Information
Article History
Received: 13 December 2023
Accepted: 5 April 2025
First Online: 13 May 2025
Declarations
:
: OCJ reports receiving speaker fees from Sanofi, Takeda, Bussié, Axon-Pharma, and Pint-Pharma; Support for attending meetings and travel from GSK, Sanofi, and Takeda; currently receives honoraria for research activities from AstraZeneca paid to his institution; additionally, was an employee of Takeda before the execution of this study. The other authors reported no potential conflict of interest.
